Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 94, Issue 1, 1997, Pages 59-66

  Dewald, Gordon W ^a   Juneau, Amy L ^a   Schad, Christopher R ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; HYDROXYUREA;

BONE MARROW TRANSPLANTATION; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 3; CHRONIC GRANULOCYTIC LEUKEMIA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LEUKEMOGENESIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOUTHERN BLOTTING; TREATMENT PLANNING;

EID: 0030944550     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00292-0     Document Type: Article

References (56)

1. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed., S. Karger, Basel.
2. Westbrook CA, Rubin CM, Carrino JJ, Le Beau MM, Bernards A, Rowley JD (1988): Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. Blood 71:697-702.
3. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G (1983): Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239-242.
4. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984): Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93-99.
5. Rodenhuis S, Smets LA, Slater RM, Behrendt H, Veerman AJ (1985): Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myelogenous leukemia (letter). N Engl J Med 313:51-52.
6. Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW (1995): Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. Cancer Genet Cytogenet 83:61-64.
7. Kantarjian HM, Deisseroth A, Kurzock R, Estrov Z, Talpaz M (1993): Chronic myelogenous leukemia: A concise update. Blood 82:691-703.
8. Appelbaum FR, Clift R, Radich J, Anasetti C, Buckner CD (1995): Bone marrow transplantation for chronic myelogenous leukemia. Semin Oncol 22:405-411.
9. McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan NA (1993): Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program. Blood 81: 543-550.
10. Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masaoka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone JA, Wingard JR, Zwaan FE, Bortin MM (1993): Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82:2235-2238.
11. Hehlmann R, Heimpel H, Hasford J, Kolb JH, Pralle H, Hossfeld DK, Quiesser W, Löffler H, Heinze B, Georgii A, von Wussow P, Bartram C, Griesshammer M, Bergmann L, Essers U, Falge C, Hochhaus A, Queisser U, Sick C, Meyer P, Schmitz N, Verpoort K, Eimermacher H, Walther F, Westerhausen M, Kleeberg UR, Heilein A, Käbisch A, Barz C, Zimmermann R, Meuret G, Tichelli A, Berdel WE, Kanz L, Anger B, Tigges FJ, Schmid L, Brockhaus W, Zankovich R, Schläfer U, Weissenfels I, Mainzer K, Tobler A, Perker M, Hohnloser J, Messener D, Thiele J, Buhr T, Ansari H (1993): Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: Prolongation of survival by hydroxyurea. The German CML Study Group. Blood 82:398-407.
12. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994): Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820-825.
13. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU (1991): Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 114:532-538.
14. Kloke O, Niederle N, Qiu JY, Wandl U, Moritz T, Nagel-Hiemke M, Hawig I, Opalka B, Seeber S, Becher R (1993): Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br J Haematol 83:399-403.
15. Allan NC, Richards SM, Shepherd PCA, on behalf of the UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia (1995): UK Medical Research Council randomised, multicentre trial of interferon-αnl for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response. Lancet 345:1392-1397.
16. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R (1986): Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 104:155-163.
17. Graham DL, Tefferi A, Letendre L, Gastineau DA, Hoagland HC, Noël P (1992): Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemia. Mayo Clin Proc 67:123-127.
18. Arcese W, Goldman JM, D'Arcangelo E, Schattenberg A, Nardi A, Apperley JF, Frassoni F, Aversa F, Prentice HG, Ljungman P, Ferrant A, Marosi C, Sayer H, Niederwieser D, Arnold R, Bandini G, Carreras E, Parker A, Frappaz D, Mandelli F, Gratwohl A (1993): Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia (Chronic Leukemia Working Party of the European Bone Marrow Transplantation Group). Blood 82:3211-3219.
19. Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH (1994): Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330:100-106.
20. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM (1993): The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7-14.
21. 1-positive chronic granulocytic leukaemia. Br J Haematol 39:305-309.
22. Hicks GA. Dewald GW (1985): Incidence and types of variant Ph chromosomes in 378 patients with a Ph chromosome (abstract). Karyogram 11:105.
23. Third International Workshop on Chromosomes in Leukemia (1981): Chromosomal abnormalities in acute lymphoblastic leukemia: Structural and numerical changes in 234 cases. Cancer Genet Cytogenet 4:101-110.
24. Fourth International Workshop on Chromosomes in Leukemia, 1982 (1984): Abnormalities of chromosome 22. Cancer Genet Cytogenet 11:316-318.
25. Hagemeijer A, Bartram CR, Smit EM, van Agthoven AJ, Bootsma D (1984): Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? Cancer Genet Cytogenet 13:1-16.
26. Heim S, Mitelman F (1995): Cancer Cytogenetics, 2nd Ed. Wiley-Liss, New York, pp. 33-68.
27. Mitelman F (1993): The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 11 Suppl 1:11-15.
28. Diez-Martin JL, Dewald GW, Pierre RV (1988): Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia. Am J Hematol 27:194-203.
29. 1-positive chronic myeloid leukemia. Blood 61:935-939.
30. Dewald GW, Wright PI (1995): Chromosome abnormalities in the myeloproliferative disorders. Semin Oncol 22:341-354.
31. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, Georgii A, Bartram CR, Griesshammer M, Bergmann L, Essers U, Falge C, Queisser U, Meyer P, Schmitz N, Eimermacher H, Walther F, Fett W, Kleeberg UR, Käbisch A, Nerl C, Zimmermann R, Meuret G, Tichelli A, Kanz L, Tigges F-J, Schmid L, Brockhaus W, Tobler A, Reiter A, Perker M, Emmerich B, Verpoort K, Zankovich R, von Wussow P, Prümmer O, Thiele J, Buhr T, Carbonnell F, Ansari H, and the German CML Study Group (1994): Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 84:4064-4077.
32. Seong DC, Song MY, Henske EP, Zimmerman SO, Champlin RE, Deisseroth AB, Siciliano MJ (1994): Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid. Blood 83:2268-2273.
33. Zhang J, Meltzer P, Jenkins R, Guan X-Y, Trent J (1993): Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood 81:3365-3371.
34. Seong DC, Liu P, Siciliano J, Zhao Y, Cork A, Henske E, Warburton D, Yu M-T, Champlin R, Trujillo JM, Deisseroth A, Siciliano MJ (1993): Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization. Cancer Genet Cytogenet 65:100-103.
35. Nylund SJ, Ruutu T, Saarinen U, Larramendy ML, Knuutila S (1994): Detection of minimal residual disease using fluorescence DNA in situ hybridization: A follow-up study in leukemia and lymphoma patients. Leukemia 8:587-594.
36. Sullivan BA, Schiffer CA, Patil SR, Hulseberg D, Leana-Cox J, Schwartz S (1995): Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia. Cancer Genet Cytogenet 82:93-99.
37. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D (1990): Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559-562.
38. Brunel V, Sainty D, Costello R, Mozziconacci M-J, Simonetti J, Arnoulet C, Coignet L, Bouabdallah R, Gastaut J-A, Gabert J, Lafage-Pochitaloff M (1995): Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 85:82-84.
39. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers G-J, van der Plas D, Grosveld G (1993): Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosom Cancer 8:237-245.
40. Nacheva E, Holloway T, Brown K, Bloxham D, Green AR (1993): Philadelphia-negative chronic myeloid leukaemia: Detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22. Br J Haematol 87:409-412.
41. Amiel A, Yarkoni S, Fejgin M, Gaber E, Nagler A, Manor Y, Lishner M (1993): Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia. Cancer Genet Cytogenet 65:32-34.
42. Amiel A, Yarkoni S, Slavin S, Or R, Lorberboum-Galski H, Fejgin M, Nagler A (1994): Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 76:59-64.
43. Cox-Froncillo MC, Cantonetti M, Masi M, Lentini R, Giudiceandrea P, Maffei L, Tribalto M, Amadori S, Papa G (1995): Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy. Cancer Genet Cytogenet 84:15-18.
44. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ (1995): Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment. Blood 86:2343-2349.
45. Weber-Matthiesen K, Pressl S, Schlegelberger B, Grote W (1993): Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. Leukemia 7:646-649.
46. Juneau A, Christensen E, Schad CR, Tefferi A, Dewald GW (1994): Fluorescence in situ hybridization (FISH) to identify Mbcr/abl fusion in interphase cells from blood smears (abstract). Applied Cytogenet 20:110.
47. Berger R, Cher SJ, Chen Z (1990): Philadelphia-positive acute leukemia: Cytogenetic and molecular aspects. Cancer Genet Cytogenet 44:143-152.
48. College of American Pathologists (1995): Molecular Oncology program 1995 Set MO-B: Final Critique.
49. Stock W, Westbrook CA, Peterson B, Arthur DC, Szatrowski TP, Silver RT, Sher DA, Wu D, Le Beau MM, Schiffer CA, Bloomfield CD (1997): Value of molecular monitoring during the treatment of chronic myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 15:26-36.
50. Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH (1985): Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 66:1436-1444.
51. Delfau MH, Kerckaert JP, Collyn d'Hooghe M, Fenaux P, Lai JL, Jouet JP, Grandchamp B (1990): Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 4:1-5.
52. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P (1995): Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118-3122.
53. Biernaux C, Sels A, Huez G, Stryckmans P (1996): Very low level of major BCR-ABL expression in blood of some healthy individuals. Bone Marrow Transplant 17 Suppl 3:S45-S47.
54. Lion T, on behalf of the European Investigators on Chronic Myeloid Leukemia Group (1994): Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplant 14:505-509.
55. Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NCP (1996): Quantitative molecular methods to monitor the response of CML patients to interferon-α. Bone Marrow Transplant 17 Suppl 3:S41-S44.
56. Zemanová Z, Michalová K, Musilová J, Lukáová M, Starý J (1994): Sequential cytogenetic study of patients after bone marrow transplantation. Cancer Genet Cytogenet 72:68-72.